StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report report published on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock.
Titan Pharmaceuticals Stock Up 8.2 %
NASDAQ:TTNP opened at $6.13 on Thursday. Titan Pharmaceuticals has a one year low of $4.24 and a one year high of $14.80. The stock has a 50 day moving average price of $5.83 and a 200 day moving average price of $6.63.
Titan Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Titan Pharmaceuticals
- How to Invest in Small Cap Stocks
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Dell Can Continue Winning in AI and Beyond
- Insider Trades May Not Tell You What You Think
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.